Loading…
avatar for Eva Essig

Eva Essig

Intellia Therapeutics, Inc.
Vice President, Regulatory Affairs
Eva is Vice President, Regulatory Affairs at Intellia Therapeutics. With over 25 years of experience in regulatory affairs, she has been involved in developing therapeutic biologics, small molecules, blood products and biosimilars. Most recently, she was Vice President, Global Regulatory Affairs - Biosimilars at Hospira/Pfizer. She holds a B.S. in Neurobiology from McGill University, Montreal, and a Ph.D. in Neuropharmacology from Bristol University, Bristol.

My Speakers Sessions

Wednesday, June 21
 

10:30am CDT